CAMBRIDGE, MA, Biopharmaceutical company developing novel medicines targeting the activation of mTORC1, today announced the completion of a $33 million Series B financing. more...
MOUNTAIN VIEW, CA, Company pioneering the new AiR (Augmented interactive Reality) computing platform, today announced that it has closed a $14 million Series B funding. more...